Good on you, biohope. I am also thinking about topping up pab at below 1c. The way I see it, strong cash position + CEO with proven solid track record + advanced technology with great potential + huge world market could make this stock a tomorrow's superstar.
Maybe I am too bullish, but I firmly believe anticancer industry would continue booming in the next few decades and Patrys has wisely stepped in the right direction since its time of inception.
Ann: Appendix 4C - Quarterly - 31 December 2015, page-7
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.419K | 2.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 40557809 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26688875 | 13 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |